Xifaxan — Medica
Hepatic encephalopathy
Initial criteria
- age ≥ 18 years
- patient has previously had overt hepatic encephalopathy
- Xifaxan will be used concomitantly with lactulose OR patient has a contraindication or significant intolerance to lactulose
Approval duration
6 months